Publications Directory

Welcome to our Publications Directory. As Australia's peak allergy research body, here you will find the latest evidence out of the drug, food, insect and respiratory allergy studies involving our leading experts and scholars.

For advice on how to acknowledge your NACE affiliation if you are involved in research supported, conducted and/or funded by the NACE, see our Publications Guidelines.
For more information about studies currently recruiting and underway across Australia, visit the NACE Allergy Studies Directory.

Filter by type:

Respiratory allergy Nov 2023
Airborne grass pollen and thunderstorms influence emergency department asthma presentations in a subtropical climate

Environmental Research.

Read more
Food allergy Oct 2023
Timing of complementary feeding for early childhood allergy prevention: An overview of systematic reviews

Clinical and Experimental Allergy.

Read more
Food allergy Oct 2023
Association of Reaction Symptoms and Eliciting Dose with Health-Related Quality of Life in Children with Peanut Allergy

The Journal of Allergy and Clinical Immunology: In Practice

Read more
Food allergy Oct 2023
Recent advances in epicutaneous immunotherapy and potential applications in food allergy

Frontiers in Allergy

Read more
Insect allergy Sep 2023
The development of Jack Jumper ant venom immunotherapy: our 25 years' experience

International Medicine Journal.

Read more
Other Sep 2023
Use of adrenaline to manage suspected anaphylaxis following COVID-19 vaccination: An Australian retrospective cohort study

Vaccine

Read more
Respiratory allergy Sep 2023
Digital inhaler preferences of asthma patients and healthcare providers: a discrete choice experiment

ERS Publications.
Other Sep 2023
Contemporary trends in anaphylaxis burden and healthcare utilisation in Western Australia: A linked data study

World Allergy Organization Journal

Read more
Food allergy Aug 2023
Thermostable allergens in canned fish: Evaluating risks for fish allergy

Allergy.

Read more
Respiratory allergy Aug 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients

Allergy.

Read more

If you would like to request a PDF version of a full article, please email [email protected]

Stay informed

Become a member

Are you part of the Australian and New Zealand allergy research community?

Join us

Publications Directory

Airborne grass pollen and thunderstorms influence emergency department asthma presentations in a subtropical climate

Timing of complementary feeding for early childhood allergy prevention: An overview of systematic reviews

Association of Reaction Symptoms and Eliciting Dose with Health-Related Quality of Life in Children with Peanut Allergy

Recent advances in epicutaneous immunotherapy and potential applications in food allergy

The development of Jack Jumper ant venom immunotherapy: our 25 years' experience

Use of adrenaline to manage suspected anaphylaxis following COVID-19 vaccination: An Australian retrospective cohort study

Digital inhaler preferences of asthma patients and healthcare providers: a discrete choice experiment

Contemporary trends in anaphylaxis burden and healthcare utilisation in Western Australia: A linked data study

Thermostable allergens in canned fish: Evaluating risks for fish allergy

Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients

In proud partnership with